Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CLGN

CollPlant Biotechnologies Ltd

Dec 13 • 04:00PM ET

3.69

Dollar change -0.20
Percentage change -5.14	%

Healthcare • Biotechnology • Israel • NASD

Peers: FATE NTLA EDIT SRPT CRIS ADVM DNLI ADAP BLUE CLLS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.52	Insider Own	31.24%	Shs Outstand	11.45M	Perf Week	-7.75%
Market Cap	42.25M	Forward P/E	-	EPS next Y	-0.18	Insider Trans	0.00%	Shs Float	7.88M	Perf Month	-14.39%
Income	-17.42M	PEG	-	EPS next Q	-0.13	Inst Own	17.50%	Short Float	0.09%	Perf Quarter	-26.35%
Sales	0.65M	P/S	65.00	EPS this Y	-74.19%	Inst Trans	1.20%	Short Ratio	0.52	Perf Half Y	-26.20%
Book/sh	1.48	P/B	2.50	EPS next Y	83.33%	ROA	-58.07%	Short Interest	0.01M	Perf Year	-26.20%
Cash/sh	1.36	P/C	2.71	EPS next 5Y	-	ROE	-70.65%	52W Range	3.31 - 6.99	Perf YTD	-42.25%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-84.92%	ROI	-89.92%	52W High	-47.21%	Beta	0.52
Dividend TTM	-	Quick Ratio	5.23	Sales past 5Y	746.60%	Gross Margin	-393.23%	52W Low	11.48%	ATR (14)	0.27
Dividend Ex-Date	-	Current Ratio	5.38	EPS Y/Y TTM	-154.03%	Oper. Margin	-2822.31%	RSI (14)	35.70	Volatility	5.35% 7.39%
Employees	75	Debt/Eq	0.19	Sales Y/Y TTM	-93.94%	Profit Margin	-2680.00%	Recom	1.00	Target Price	14.00
Option/Short	Yes / Yes	LT Debt/Eq	0.15	EPS Q/Q	1.25%	Payout	-	Rel Volume	1.40	Prev Close	3.89
Sales Surprise	-99.04%	EPS Surprise	-33.33%	Sales Q/Q	-90.70%	Earnings	Nov 27 BMO	Avg Volume	12.90K	Price	3.69
SMA20	-10.34%	SMA50	-10.92%	SMA200	-25.21%	Trades		Volume	18,017	Change	-5.14%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-17-23	Initiated	Alliance Global Partners	Buy	$22.75

Nov-27-24 07:00AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)
Nov-26-24 07:01AM	What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings (GuruFocus.com)
Nov-12-24 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire) +10.80%
Aug-20-24 11:52AM	CLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
07:28AM	CollPlant Biotechnologies Posts Loss In Q2 - Quick Facts (RTT News)
07:00AM	Loading…
07:00AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)
Aug-19-24 08:30AM	CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants (PR Newswire) +5.48%
Aug-06-24 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Jul-29-24 07:00AM	CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report (PR Newswire)
Jun-06-24 07:00AM	CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data (PR Newswire)
May-30-24 08:02AM	CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-29-24 11:53AM	CLGN Stock Earnings: CollPlant Biotechnologies Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:00AM	CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update (PR Newswire)
May-16-24 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
May-10-24 09:51AM	CollPlant Biotechnologies (CLGN) Soars 8.2%: Is Further Upside Left in the Stock? (Zacks)
09:19AM	Loading…
Apr-08-24 09:19AM	CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Apr-04-24 11:52AM	CLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
07:17AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)
Mar-26-24 08:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Feb-15-24 08:00AM	CollPlant Issues Letter to Shareholders (PR Newswire)
Jan-08-24 07:18AM	CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California (PR Newswire)
Jan-02-24 07:00AM	CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants (PR Newswire) -5.32%
Dec-01-23 09:58AM	CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-29-23 07:00AM	CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023 (PR Newswire) -6.63%
Nov-09-23 08:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Nov-01-23 07:05AM	CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler (PR Newswire) +24.11%
Sep-21-23 07:00AM	CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative (PR Newswire)
Sep-05-23 07:00AM	CollPlant to Present at the H.C. Wainwright Annual Growth Conference (PR Newswire)
Aug-24-23 07:00AM	CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million (PR Newswire) +6.87%
Aug-09-23 08:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
07:00AM	Loading…
Jun-26-23 07:00AM	CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement (PR Newswire)
May-24-23 07:00AM	CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update (PR Newswire) +5.69%
May-02-23 09:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Apr-04-23 08:26AM	Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs (Business Wire) +5.28%
Mar-29-23 07:00AM	Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update (PR Newswire) -9.89%
Mar-14-23 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire) +7.93%
Jan-24-23 07:00AM	CollPlant Issues Letter to Shareholders (PR Newswire)
Jan-04-23 07:00AM	CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives (PR Newswire) +9.65%
Jan-03-23 07:00AM	CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder Form (PR Newswire)
Dec-12-22 09:50AM	We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth (Simply Wall St.) +6.58%
Dec-01-22 07:00AM	CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results (PR Newswire)
Nov-15-22 07:00AM	CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative Colitis (PR Newswire)
Nov-07-22 07:00AM	CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D 90 (PR Newswire) -5.80%
Nov-03-22 07:00AM	CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17 (PR Newswire)
Oct-03-22 07:00AM	CollPlant to present at the Dawson James Small Cap Growth Conference on October 12 (PR Newswire)
Sep-19-22 07:00AM	CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy (PR Newswire)
Sep-06-22 07:00AM	CollPlant Biotechnologies to Participate in September Investor Conferences (PR Newswire)
Aug-25-22 07:00AM	CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results (PR Newswire)
Jul-05-22 10:27AM	We're Hopeful That CollPlant Biotechnologies (NASDAQ:CLGN) Will Use Its Cash Wisely (Simply Wall St.)
07:00AM	CollPlant to Present and Exhibit at TERMIS Annual Conference in Toronto, Canada (PR Newswire)
Jun-29-22 08:45AM	CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine Study (PR Newswire) +10.54%
May-26-22 07:00AM	CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results (PR Newswire)
May-23-22 08:00AM	Enlivex Appoints Dr. Roger J. Pomerantz to its Board of Directors as Vice Chairman (GlobeNewswire)
May-21-22 08:59AM	The 22% return this week takes CollPlant Biotechnologies' (NASDAQ:CLGN) shareholders three-year gains to 141% (Simply Wall St.)
Apr-25-22 07:00AM	CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and Screening (PR Newswire)
Apr-13-22 07:00AM	CollPlant To Present at the Aesthetics Innovation Summit 2022 (PR Newswire)
Apr-09-22 09:33AM	Is CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Shareholder Ownership Skewed Towards Insiders? (Simply Wall St.)
Mar-24-22 07:00AM	CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial Results (PR Newswire) +15.11%
Feb-16-22 08:00AM	CELLINK and CollPlant Enter a Collaboration Agreement to Explore Future Large-Scale Production of CollPlant's Regenerative Breast Implants using CELLINK's Bioprinting technologies (PR Newswire) +15.08%
Feb-03-22 07:06AM	A Look At The Intrinsic Value Of CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) (Simply Wall St.)
Jan-05-22 07:00AM	CollPlant Issues Letter to Shareholders (PR Newswire) -8.25%
Dec-05-21 07:26AM	CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? (Simply Wall St.)
Dec-02-21 07:00AM	CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery Journal (PR Newswire)
Nov-18-21 07:00AM	CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results (PR Newswire) -8.44%
Nov-15-21 07:00AM	CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D for Use in 3D Bioprinting of Human Tissues, Scaffolds and Organs (PR Newswire)
Oct-14-21 07:00AM	CollPlant to Present at Dawson James Small Cap Growth Conference on October 21st (PR Newswire)
Oct-11-21 07:00AM	CollPlant's rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue Constructs (PR Newswire)
Oct-04-21 04:30PM	36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021 (ACCESSWIRE)
Sep-30-21 07:00AM	CollPlant to Present at Fall Harvest - Best Ideas from the Buy-Side on October 5, 2021 (PR Newswire)
Sep-27-21 07:00AM	CollPlant CEO Yehiel Tal to Discuss Emerging Uses of rhCollagen in Aesthetic and Regenerative Medicine at NANO.IL.2021 Conference (PR Newswire)
Sep-09-21 07:00AM	CollPlant CEO Yehiel Tal elected to the Board of Directors of the International Society for Biofabrication (ISBF) (PR Newswire)
Sep-07-21 07:00AM	CollPlant To Present at the H.C. Wainwright Annual Global Investment Conference in September (PR Newswire)
Sep-06-21 07:05AM	CollPlant Biotechnologies' (NASDAQ:CLGN) investors will be pleased with their strong 245% return over the last three years (Simply Wall St.)
Aug-19-21 08:00AM	CollPlant Appoints Medical Aesthetics Veteran Alisa Lask to Board of Directors (PR Newswire)
07:00AM	CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results (PR Newswire)
Aug-16-21 09:10AM	CollPlant Biotechnologies to Present on the Use of Collagen BioInk as a Platform for 3D Bioprinting of Tissues and Organs at the Biomaterials For 3D Printing Webinar (PR Newswire)
Jun-22-21 08:30AM	3D Systems and CollPlant Enter Co-development Agreement to Deliver Bioprinted Solutions for Improved Breast Reconstruction Treatments (GlobeNewswire) +12.62%
Jun-04-21 07:00AM	CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSs (PR Newswire)
May-27-21 07:00AM	CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 Million (PR Newswire)
May-25-21 09:00AM	CollPlant Announces Uplisting to the Nasdaq Global Market® and Transition to Trading of Ordinary Shares Instead of ADSs (PR Newswire)
May-17-21 02:32AM	If You Had Bought CollPlant Biotechnologies (NASDAQ:CLGN) Stock Three Years Ago, You Could Pocket A 146% Gain Today (Simply Wall St.)
Apr-07-21 11:30AM	Is CollPlant Biotechnologies Ltd. Sponsored (CLGN) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-29-21 07:00AM	CollPlant Appoints Additive Manufacturing Executive, Hugh Evans to Its Board of Directors (PR Newswire)
Mar-26-21 09:00AM	CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2020 (PR Newswire)
Mar-18-21 11:30AM	Has CollPlant Biotechnologies Ltd. Sponsored (CLGN) Outpaced Other Medical Stocks This Year? (Zacks)
02:12AM	What Type Of Shareholders Make Up CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Share Registry? (Simply Wall St.)
Mar-04-21 07:00AM	CollPlant To Present at the H.C. Wainwright Global Life Sciences Conference (PR Newswire) -5.02%
Feb-25-21 09:20AM	Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants (PR Newswire) -30.07%
Feb-18-21 09:20AM	CollPlant Issues Letter to Shareholders (PR Newswire)
07:00AM	CollPlant Announces Closing of $35.0 Million Registered Direct Offering of American Depositary Shares (GlobeNewswire)
Feb-11-21 11:23PM	CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares (GlobeNewswire) +5.80% -32.16%
Feb-08-21 07:00AM	CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products (PR Newswire) +20.09%
Jan-27-21 08:30AM	3D Systems Announces Breakthrough in Bioprinting Technology and Expansion of Regenerative Medicine Initiative (GlobeNewswire) +14.86%
Jan-17-21 02:13AM	CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) About To Shift From Loss To Profit (Simply Wall St.)
Dec-10-20 07:00AM	CollPlant to Supply rhCollagen to STEMCELL Technologies for Use in a Broad Range of Cell Culture Applications (PR Newswire) +7.46%
Dec-02-20 11:50PM	How Should Investors Feel About CollPlant Biotechnologies' (NASDAQ:CLGN) CEO Remuneration? (Simply Wall St.) -8.80%
Dec-01-20 07:00AM	CollPlant Biotechnologies Reports Third Quarter (Q3) 2020 Financial Results and Provides Business Update (PR Newswire) +29.00%
Nov-10-20 07:00AM	CollPlant Announces Early Development Program of Antiviral Agent for Potential Treatment of COVID-19 Patients (PR Newswire) +8.33%
Oct-26-20 07:00AM	CollPlant Receives Substantial First Order for its Vergenix Flowable Gel Product in Ukraine (PR Newswire)
Oct-09-20 07:27AM	If You Had Bought CollPlant Biotechnologies (NASDAQ:CLGN) Stock A Year Ago, You Could Pocket A 92% Gain Today (Simply Wall St.)

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CLGN

CollPlant Biotechnologies Ltd

Upgrade your FINVIZ experience